Suppr超能文献

用渥曼青霉素处理间充质干细胞条件培养基,通过PI3K/Akt/mTOR途径增强其对乳腺癌细胞的抗增殖作用。

Impregnation of mesenchymal stem cell conditioned media with wortmannin enhanced its antiproliferative effect in breast cancer cells via PI3K/Akt/mTOR pathway.

作者信息

Ismail Doha F, El-Keey Mai M, Elgendy Saad M, Hessien Mohamed

机构信息

Molecular Cell Biology Unit, Division of Biochemistry, Faculty of Science, Tanta University, Tanta, 31527, Egypt.

Department of Cancer Biology, National Cancer Institute, Cairo University, Cairo, Egypt.

出版信息

BMC Res Notes. 2025 Mar 4;18(1):93. doi: 10.1186/s13104-025-07124-3.

Abstract

BACKGROUND/AIM: Conditioned media derived from Mesenchymal stem cells (MSC-CM) was suggested as a promising alternative cell-free regenerative therapy. It is hypothesized that the synergistic effect of MSC-CM with anticancer drugs may improve their antiproliferative and antimetastatic effects against cancer cells. Herein, the MSC-CM was impregnated with Wortmannin, a pan-PI3K/Akt/mTOR inhibitor, and their combined effect was investigated against breast cancer cells.

MATERIALS AND METHODS

To explore this, the cytotoxic, apoptotic, and autophagic potentials were assessed in luminal-A breast cancer cells (MCF-7).

RESULTS

We found that incubation of MCF-7 to Wort-containing-CM induced apoptosis- and autophagy-mediated cell death, meanwhile prolonged exposure caused massive necrotic cell death. The involvement of MSC-CM effectively reduced Wortmannin IC50 observed in Wort-treated cells. Also, Wort-loaded-CM induced nuclear DNA fragmentation and reduced in vitro cell migration. These findings were associated with a Wort-dependent reduction in cell viability, the formation of the phosphorylated Akt and mTOR proteins, reduced the expression of mRNA, and downregulated the expression of the catalytic domain of phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K-Ca).

CONCLUSION

These findings revealed the promising antiproliferative and antimetastasis effects of combining pan-PI3K/Akt/mTOR inhibitors with MSC-derived-CM in breast cancer via the downregulation of PI3K/AKT/mTOR signaling pathways. Further studies are required to validate this chem-regenerative strategy in cancer treatment.

摘要

背景/目的:间充质干细胞条件培养基(MSC-CM)被认为是一种有前景的无细胞再生疗法。据推测,MSC-CM与抗癌药物的协同作用可能会增强其对癌细胞的抗增殖和抗转移作用。在此,将泛PI3K/Akt/mTOR抑制剂渥曼青霉素加载到MSC-CM中,并研究它们对乳腺癌细胞的联合作用。

材料与方法

为了探究这一点,评估了其对腔面A型乳腺癌细胞(MCF-7)的细胞毒性、凋亡和自噬潜力。

结果

我们发现,将MCF-7与含渥曼青霉素的CM一起孵育会诱导凋亡和自噬介导的细胞死亡,同时长时间暴露会导致大量坏死性细胞死亡。MSC-CM的参与有效降低了渥曼青霉素处理细胞中观察到的IC50。此外,负载渥曼青霉素的CM诱导核DNA片段化并减少体外细胞迁移。这些发现与渥曼青霉素依赖性的细胞活力降低、磷酸化Akt和mTOR蛋白的形成减少、mRNA表达降低以及磷脂酰肌醇-4,5-二磷酸3-激酶(PI3K-Ca)催化结构域的表达下调有关。

结论

这些发现揭示了通过下调PI3K/AKT/mTOR信号通路,将泛PI3K/Akt/mTOR抑制剂与MSC来源的CM联合使用对乳腺癌具有有前景的抗增殖和抗转移作用。需要进一步研究来验证这种癌症治疗中的化学再生策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ff/11877855/36dc32dd4185/13104_2025_7124_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验